ClinicalTrials.Veeva

Menu

Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Postpartum. Hypertension

S

Sohag University

Status

Enrolling

Conditions

Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension

Study type

Observational

Funder types

Other

Identifiers

NCT06500351
Soh-Med-24-06-08PD

Details and patient eligibility

About

This is an observertional study aimed at Study the association between Renalase(rs10887800) Genotyping & Leucocytes telomere length in patients with postpartum hypertension whether new onset( denovo) or persistent following pregnancy complicated by hypertension.

Enrollment

90 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who are18 years or above, and have a diagnosis of postpartum hypertension(regardless of where they received their antenatal care) attended to Sohag university hospitals

Exclusion criteria

  • All pregnant women with medical disorders in pregnancy other than Hypertensive disorders during pregnancy (e.g., sickle cell disease, heart disease, kidney and other connective tissues disorders) will be excluded from the study. Also we excluded measurements taken during scheduled or unscheduled surgical encounters given potential for interaction with anesthetic agents

Trial design

90 participants in 3 patient groups

denovo postpartum hypertension
Description:
females with new onset hypertension after delivary
persitant postpartum hypertension
Description:
females with preexisting hypertension or preeclampsia that persist after delivery
control
Description:
females with normal postpartum blood pressure

Trial contacts and locations

1

Loading...

Central trial contact

Amera Morad Foad, assistant professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems